---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-022858"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2025-03-12T23:59:59+00:00"
generated_at: "2026-05-24T22:47:13.827825+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Denali Capital extends business combination deadline to April 11 via $15K trust deposit

## Summary
- Deposited $15,063.74 into trust to extend deadline from March 11 to April 11, 2025.
- Funding via convertible promissory note from Scilex (SCLX) with principal up to $180,000.
- Note bears no interest, convertible into Class A shares at $10.00 per share upon closing.
- Remaining $59,545.08 under note available for future one-month extensions.
- Company is a blank check SPAC seeking a merger or acquisition.

## SEC filing metadata
- accession: 0001213900-25-022858
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2025-03-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000121390025022858/0001213900-25-022858-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000121390025022858/ea0234000-8k425_denalicap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-022858
- JSON: https://secwatch.observer/filing/0001213900-25-022858.json
- Plain text: https://secwatch.observer/filing/0001213900-25-022858.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.